Radiation exposure to family members of patients with thyrotoxicosis treated with iodine-131

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 33, Issue 1, 2006, Pages 81-86

  Cappelen, Tone ^a   Unhjem, Jan Frede ^b   Amundsen, Anne Lise ^a   Kravdal, Gunnhild ^a   Følling, Ivar ^a  

^a AKERSHUS UNIVERSITY HOSPITAL   (Norway)

^b NORWEGIAN RADIATION PROTECTION AUTHORITY   (Norway)

Author keywords

Guidelines; Iodine 131 therapy; Radiation protection; Thyrotoxicosis

Indexed keywords

IODINE 131;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CONTROLLED STUDY; FAMILY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; OUTPATIENT; PRACTICE GUIDELINE; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; RADIATION EXPOSURE; THERMOLUMINESCENCE DOSIMETER; THYROTOXICOSIS;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; AGED; CHILD; ENVIRONMENTAL EXPOSURE; EUROPEAN UNION; FAMILY; FEMALE; HUMANS; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; NORWAY; PRACTICE GUIDELINES; RADIATION DOSAGE; RADIATION MONITORING; RADIATION PROTECTION; RADIOPHARMACEUTICALS; RISK ASSESSMENT; RISK FACTORS; THYROTOXICOSIS;

EID: 28944451047     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-005-1888-7     Document Type: Article

References (18)

1. Hoefnagel CA, Clarke SE, Fischer M, Chatal JF, Lewington VJ, Nilsson S, et al. EANM Radionuclide Therapy Committee. Eur J Nucl Med 1999;26:277-82
2. 131I therapy for thyrotoxicosis towards 2000. Eur J Nucl Med 1996;23:BP13-5
3. Lassman M, Hänscheid H, Schelper LF. Measurement of incorporation in family members of patients with benign thyroid disease after radioiodine therapy. Nuklearmedizin 1998;37:120-3
4. 131I after radioiodine therapy: time dependence and chemical form. Proceedings of the 47th annual meeting, Society of Nuclear Medicine (abstract). J Nucl Med 2000;41 Suppl:251P
5. Jacobson AP, Plato PA, Toeroek D. Contamination of the home environment by patients treated with iodine-131: initial results. Am J Public Health 1978;68:225-30
6. Council of the European Union. Guideline 96/29/EURATOM to determine basic directions for health protection of public and workers against ionizing radiation related dangers. Leafl Eur Commun 1996;L159/1
7. Council of the European Union. Directive on the health protection of individuals against the dangers of ionizing radiation in relation to medical exposures. 97/43/Euratom OJ 1997;L180:22-7
8. International Commission on Radiological Protection. Recommendations of the International Commission on Radiological Protection. Ann ICRP 1991;21(1-3)
9. European Commission. Radiation protection 97: radiation protection following iodine-131 therapy (exposures due to outpatients or discharged inpatients). Luxembourg, Belgium: Office for Official Publications of the European Communities; 1998
10. Monsieurs M, Thierens H, Dierckx RA, Casier K, De Baere E, De Ridder L, et al. Real-life radiation burden to relatives of patients treated with iodine-131: a study in eight centers in Flanders (Belgium). Eur J Nucl Med 1998;25:1368-76
11. Barrington SF, O'Doherty MJ, Kettle AG, Thomson WH, Mountford PJ, Burell DN, et al. Radiation exposure of the families of outpatients treated with radio iodine (iodine-131) for hyperthyroidism. Eur J Nucl Med 1999;26:686-92
12. Thomson WH, Mills AP, Smith NB, Mostafa AB, Notghi A, Harding LK. Radiation doses to patient's relatives: day and night components and their significance in terms of ICRP 60. Eur J Nucl Med 1993;993 poster nr 697
13. Barrington SF, Kettle AG, Mountford PJ, Thomson WH, Batchelor S, Burrell DN, et al. Radiation exposure of patient's children at home post I-131 administration. Eur J Nucl Med 1995;22:798
14. 131I treatment. Lancet 1997;350:1074-5
15. 131I therapy for thyrotoxicosis. Nucl Med Commun 1993;14:160-8
16. 131I treatment of thyrotoxic outpatients. Nucl Med Commun 1993;14:756-60
17. Cappelen T, Unhjem JF. Patients with hyperthyroidism treated with radioactive iodine and exposures to family members. Eur J Nucl Med Mol Imaging 2004;31:P828, S457
18. Regulations No. 1362 of 21. November 2003 on Radiation Protection and Use of Radiation (Norwegian Radiation Protection Regulation)